Login
Toggle navigation
Videos
Categories
Trending
Olivia Lum is Group CEO and President of ground-breaking water treatment company Hyflux Ltd, one of Asia's largest in water and fluid solutions.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Olivia Lum is Chairman/CEO at Hyflux Ltd.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
James' Vision for Bridge Biotherapeutics: Advancing Pulmonary Fibrosis, Lung Cancer, and Immunology Treatments| James Lee, CEO , Bridge Biotherapeutics Inc.
00:10:00
Alex Griffin on Transitioning from Banking to Independent Advising: A Journey of Intentional Change
00:10:00
Eritrea's Mining Potential: A Conversation with Theo Batulis of Anyama Exploration
00:10:00
Strategic Metals: Capitalizing on Yukon's Mining Potential
00:00:00
Admedus (ASX:AHZ) CEO Wayne Paterson podcast
00:10:00
Thys van Zyl Analyzes President Ramaphosa's State of the Union Address | Thys van Zyl, CEO, Everest Wealth Management, LLC.
00:10:00
Childhood Memories and Creative Innovation in Global Fashion Collaboration
00:10:00
Unlocking Mineral Potential: Arabian & Nubian Shields | Al Workman, Vice President and Owner, Watts, Griffis McOuat Ltd
00:10:00
5 Tax-Saving Strategies to Implement Before the New Year | Ben Smith, Founder, Cove Financial Planning, LLC.
00:10:00
Brickworks Ltd MD Discusses Full Year Results, Property Trust, and Dividend Policy with Tom Piotrowski | Lindsay Partridge - CEO of brickworks ltd
00:10:00
Moosehead Project's Geological Similarities and Potential
00:10:00
crypto companies with big ambitions and contrarian worldviews|Robert Leshner,Partner,Robot Ventures